UNIGE document Scientific Article
previous document  unige:42490  next document
add to browser collection
Title

The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents
Authors
Barone-Rochette, Gilles
Machecourt, Jacques
Vanzetto, Gerald
Foote, Alison
Quesada, Jean-Louis
Castelli, Christel
Danchin, Nicolas
Combescure, Christophe
Published in International Journal of Cardiology. 2013, vol. 168, no. 2, p. 1466-71
Abstract We aimed to assess the cost effectiveness of the sirolimus-eluting stent (SES) in diabetic and non-diabetic patients vs. bare metal stents (BMS).
Keywords Aged — Cohort Studies — Cost-Benefit Analysis/methods/trends — Drug-Eluting Stents/economics/trends — Female — Follow-Up Studies — Humans — Male — Metals/economics — Middle Aged — Myocardial Revascularization/economics/trends — Registries — Risk Factors — Stents/economics/trends
Identifiers
PMID: 23336951
Full text
Article (Published version) (629 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires / Institut de médecine de premier recours
Research group Epidémiologie clinique (115)
Citation
(ISO format) 		BARONE-ROCHETTE, Gilles et al. The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents. In: International Journal of Cardiology, 2013, vol. 168, n° 2, p. 1466-71. doi: 10.1016/j.ijcard.2012.12.054 https://archive-ouverte.unige.ch/unige:42490

409 hits

0 download

Contact an author

Update request

Update

Deposited on : 2014-12-04

Export document
Format :
Citation style :